Gabelli Funds LLC Amgen Inc Transaction History

Gabelli Funds LLC

$12.3 Billion
Q2 2024

A detailed history of Gabelli Funds LLC transactions in Amgen Inc stock. As of the latest transaction made, Gabelli Funds LLC holds 51,380 shares of AMGN stock, worth $16.6 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

51,380

Previous 51,415 0.07%

Holding current value

$16.6 Million

Previous $14.6 Million 9.82%

% of portfolio

0.13%

Previous 0.12%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$262.75 - $319.31 $9,196 - $11,175	-35 Reduced 0.07%	51,380 $16.1 Million
Q1 2024 May 14, 2024	BUY	$268.87 - $324.56 $4,033 - $4,868	15 Added 0.03%	51,415 $14.6 Million
Q4 2023 Feb 13, 2024	SELL	$255.7 - $288.46 $549,755 - $620,189	-2,150 Reduced 4.01%	51,400 $14.8 Million
Q3 2023 Nov 08, 2023	SELL	$218.65 - $271.46 $146,495 - $181,878	-670 Reduced 1.24%	53,550 $14.4 Million
Q2 2023 Aug 10, 2023	SELL	$214.27 - $253.37 $113,563 - $134,286	-530 Reduced 0.97%	54,220 $12 Million
Q1 2023 May 12, 2023	BUY	$225.79 - $275.2 $62,092 - $75,680	275 Added 0.5%	54,750 $13.2 Million
Q4 2022 Feb 13, 2023	BUY	$229.03 - $291.01 $74,434 - $94,578	325 Added 0.6%	54,475 $14.3 Million
Q3 2022 Nov 10, 2022	BUY	$224.46 - $253.15 $50,727 - $57,211	226 Added 0.42%	54,150 $12.2 Million
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $37,147 - $43,522	-175 Reduced 0.32%	53,924 $11.5 Million
Q1 2021 May 14, 2021	BUY	$221.91 - $258.6 $132,924 - $154,901	599 Added 1.12%	54,099 $13.5 Million
Q3 2020 Nov 06, 2020	SELL	$234.65 - $260.95 $82,127 - $91,332	-350 Reduced 0.65%	53,500 $13.6 Million
Q2 2020 Aug 13, 2020	SELL	$197.81 - $242.74 $108,795 - $133,507	-550 Reduced 1.01%	53,850 $12.7 Million
Q1 2020 May 14, 2020	SELL	$182.24 - $241.7 $200,464 - $265,870	-1,100 Reduced 1.98%	54,400 $11 Million
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $567,630 - $729,600	-3,000 Reduced 5.13%	55,500 $13.4 Million
Q3 2019 Nov 01, 2019	SELL	$174.11 - $208.62 $696,440 - $834,480	-4,000 Reduced 6.4%	58,500 $11.3 Million
Q4 2018 Jan 30, 2019	SELL	$178.4 - $208.25 $356,800 - $416,500	-2,000 Reduced 3.1%	62,500 $12.2 Million
Q3 2017 Nov 01, 2017	BUY	$167.29 - $191.0 $10.8 Million - $12.3 Million	64,500	64,500 $12 Million

Others Institutions Holding AMGN

# of Institutions

3,054

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $173B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gabelli Funds LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gabelli Funds LLC with notifications on news.

Account

Gabelli Funds LLC Amgen Inc Transaction History